The estimated Net Worth of Jonathan E Rothschild is at least $1.93 Milion dollars as of 29 January 2016. Mr. Rothschild owns over 9,522 units of Immucell stock worth over $1,933,499 and over the last 21 years he sold ICCC stock worth over $0. In addition, he makes $0 as Independent Director at Immucell.
Jonathan has made over 55 trades of the Immucell stock since 2003, according to the Form 4 filled with the SEC. Most recently he bought 9,522 units of ICCC stock worth $49,991 on 29 January 2016.
The largest trade he's ever made was buying 24,000 units of Immucell stock on 11 November 2015 worth over $90,960. On average, Jonathan trades about 3,273 units every 77 days since 2003. As of 29 January 2016 he still owns at least 510,158 units of Immucell stock.
You can see the complete history of Mr. Rothschild stock trades at the bottom of the page.
Jonathan E. Rothschild serves as Independent Director of the Company. Mr. Rothschild is a member of the Audit Committee and the Compensation and Stock Option Committee of the Board of Directors. Since 1981, he has been President and CEO of Arterio, Inc., of Concord, California, a vitamin and supplement company that does business as Ecological Formulas. Mr. Rothschild served on the Board of Directors of CCA Industries, Inc. of East Rutherford, New Jersey (a developer and marketer of health and beauty products) from August 2012 through December 2014. He served as a director of the Anne Frank Center USA, a not-for-profit organization, from 1994 to 2017. He served as a director and Chief Financial Officer of Cistron Biotechnology from 1999 until it was acquired by Celltech, PLC in November 2000.
Jonathan Rothschild is 66, he's been the Independent Director of Immucell since 2001. There are no older and 10 younger executives at Immucell.
Jonathan's mailing address filed with the SEC is C/O IMMUCELL CORP, 56 EVERGREEN DRIVE, PORTLAND, ME, 04103.
Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin a Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.
immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.
Immucell executives and other stock owners filed with the SEC include: